Price Registration Aimed at the Eventual Acquisition of Medications and Manipulated... Tender

Procurement Summary

Country : Brazil

Summary : Price Registration Aimed at the Eventual Acquisition of Medications and Manipulated Chemical Materials to Meet the Demand of the Hospital Das Clinicas De Pernambuco - Ebserh Branch.

Deadline : 26 Feb 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 96944883

Document Ref. No. : 90014/2024

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Object: Electronic Auction - Price Registration aimed at the eventual acquisition of Medicines and Manipulated Chemical Materials to meet the demand of the Hospital das Clinicas de Pernambuco - Ebserh Branch.

UASG Code: 155022

Notice from: 02/14/2024 at 08 :00 to 12:00 and from 14:00 to 16:0019981d172c851bd4e8a1788d5726c2d3Hs

Proposal Delivery: from 02/14/2024 at 8:00am

BORIC ACID, DOSAGE 2% SOLUTION

Quantity: 20

TRICHLOROACETIC ACID (TCA), DOSAGE 60%, PRESENTATION AQUEOUS SOLUTION

Quantity: 20

TRICHLOROACETIC ACID (TCA), DOSAGE 80%, AQUEOUS SOLUTION PRESENTATION

Quantity: 20

TRICHLOROACETIC ACID19981d172c851bd4e8a1788d5726c2d3TICO (TCA), DOSAGE 90%, PRESENTATION AQUEOUS SOLUTION

Quantity: 20

ANALYTICAL REAGENTS 2, SODIUM BISSULFITE REAGENT, CONCENTRATION 5% SOLUTION

Quantity: 15

CAFFEINE, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, CHARACTERISTICS ADDITIONAL SPECIALLY HANDLED

Quantity: 150

SILDE19981d172c851bd4e8a1788d5726c2d3NAFILA, CONCENTRATION 5 MG, ORAL PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION

Quantity: 45

ANALYTIC REAGENT 2, COMPONENTS PHENOLPHTHALEIN, CONCENTRATION 1% SOLUTION

Quantity: 12

FOLINIC ACID, CONCENTRATION 5 MG/ML, PHARMAC FORM EUTICA ORAL SOLUTION, ADDITIONAL19981d172c851bd4e8a1788d5726c2d3SPECIALLY HANDLED

Quantity: 24

TRICALCIC PHOSPHATE, COMPOSITION CALCIUM PHOSPHORUS, CONCENTRATION 60 32 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED MEDICATION

Quantity: 200

FUROSEMIDE, COMPOSITION 10 MG/ML, SOLUTION PRESENTATION ORAL

Quantityof: 65

CHLORAL HYDRATE, CONCENTRATION 200 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED

Quantity: 12

REAGENTS FOR CLINICAL DIAGNOSIS 5, TYPE SODIUM HYDROxIDE SOLUTION, ADDITIONAL CHARACTERISTICS 0.11 N

Qua ntity: 12

INDOMETHACIN, CONCENTRATION19981d172c851bd4e8a1788d5726c2d31 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL CHARACTERISTICS FORMULATION ...

Documents

 Tender Notice